Few professions ask their newest members to make consequential decisions while as sleep-deprived as medical residency does. Even after duty-hour reforms, residents in many programs routinely work 24-hour or longer shifts, average well under seven hours of sleep across a rotation, and are expected to prescribe, operate, and diagnose at the end of those stretches. It is not surprising that some residents have quietly turned to a wakefulness-promoting agent to get through call. What is surprising is how little open discussion the practice has received, given that it sits at the intersection of patient safety, professional ethics, and the pharmacology of drugs that were, in a sense, designed for exactly this problem.
The scale of the sleep problem in residency
Research on resident sleep is unambiguous. Studies using wrist actigraphy have found that residents on call frequently get fewer than three hours of sleep during a 24-hour shift, and that the cumulative effect over a month of call is a chronic debt equivalent to several nights of total sleep loss. Interns working traditional extended shifts have been shown to make substantially more serious medical errors than those on schedules that limit continuous duty. Post-call residents also have elevated rates of needle-stick injuries and motor vehicle crashes on the drive home.
Reforms have capped weekly hours in many countries, but the capping has been uneven, enforcement is imperfect, and some data suggest that compressed schedules with more handoffs create their own risks. The problem has been mitigated, not solved, and residents are still doing cognitively demanding work in a state that would be illegal for a commercial pilot or truck driver.
What eugeroics offer in this setting
Modafinil and armodafinil promote wakefulness through dopamine transporter inhibition with downstream effects on orexin and histamine signaling. They do not produce the euphoria, sympathetic overdrive, or dependence of amphetamines, and they are Schedule IV in the US. Their approved indications include shift work disorder, which is arguably what residency amounts to.
The relevant evidence comes from several directions:
- Sleep-deprivation studies in healthy volunteers show that modafinil at 200 to 400 mg preserves attention, reaction time, and working memory during 24 to 64 hours of wakefulness, with effects comparable to or better than caffeine and with less disruption of subsequent recovery sleep than dextroamphetamine.
- Shift-work trials demonstrate reduced sleepiness and fewer attention lapses during simulated night shifts, along with improved alertness on the commute home.
- Physician-specific studies are fewer but exist. At least one randomized trial gave emergency physicians modafinil after a night shift and found improved performance on cognitive tests and reduced sleepiness, though also more difficulty falling asleep afterward. Another studied surgeons performing simulated tasks after sleep deprivation and found modafinil improved planning and working memory but not manual dexterity.
A general pattern emerges: the drug helps most with sustained attention and executive function, the faculties that erode first under sleep loss and that matter for tasks like reviewing a medication list, and helps least with fine motor skills and with the deep, integrative judgment that experienced clinicians rely on. For a resident considering a wakefulness-promoting agent before a 28-hour shift, that distinction defines what to expect.
How common is use?
Surveys of residents and medical students, mostly conducted anonymously, report lifetime use of prescription stimulants for performance in the range of a few percent to around one in ten, depending on the specialty and country. Modafinil is typically the most common agent after prescription amphetamine products. Use is more often reported in surgical and emergency specialties and among residents who describe their programs as having high call burdens. Most users describe intermittent, call-linked use rather than daily consumption.
Under-reporting is likely, both because the drugs are controlled substances and because residents fear professional consequences. What is clear is that the practice exists at a meaningful scale and is largely invisible to program directors.
The ethical arguments in favor
Proponents make several points.
Patient safety. If sleep deprivation is a known cause of medical error and the drug reduces the cognitive deficits of sleep deprivation, then using it may protect patients. A resident who takes modafinil before a night of call and consequently catches a dosing error has arguably done something ethically good.
Consistency. Medicine already tolerates, and at times encourages, caffeine in enormous quantities to accomplish the same goal. Objecting to a safer, longer-acting agent while distributing free coffee in the residents’ lounge is hard to defend on principle.
Autonomy. Residents are adults and physicians. If a drug is legal with a prescription, has a favorable safety profile, and the resident has weighed the risks, the decision is arguably theirs.
Harm reduction. Residents who feel they must stay awake will find a way. Given a choice between modafinil and escalating caffeine, energy drinks, or amphetamine diverted from an ADHD prescription, the eugeroic is the least harmful option.
The ethical arguments against
The counterarguments are at least as substantial.
Enabling a broken system. The deeper problem is scheduling that demands 24 or more continuous hours of work. Pharmacologically enabling residents to tolerate it removes pressure to reform the system and shifts the burden from the institution to the individual’s body. Every resident who copes chemically makes it easier to keep the schedule unchanged.
Coercion and fairness. If some residents use a drug that improves performance under sleep loss, others may feel pressure to do the same to keep up, particularly in competitive specialties where evaluations determine fellowship placement. Voluntary use can become quasi-mandatory without anyone intending it.
Masking rather than fixing. Modafinil suppresses the signs of sleep pressure but not the underlying deficit. Studies show the drug can increase confidence more than it improves complex judgment, which is dangerous in a context where knowing what you do not know is a core skill. A resident who feels sharp but has impaired insight may be more hazardous than one who feels exhausted and asks for help.
Health of the resident. Chronic sleep restriction has cardiovascular, metabolic, and mental-health consequences that no wakefulness drug prevents. Residents already have high rates of depression and burnout; a drug that lets them sleep even less is not obviously in their interest.
Professional integrity. Physicians who use a controlled substance for performance without a prescription are breaking the law, however low the abuse potential. Programs that know and ignore this create a culture in which rules are optional.
Where the arguments converge
Most bioethicists who have written on the topic land in a similar place: occasional use of a well-tolerated eugeroic by a resident who has a prescription and has considered the risks is defensible, while institutional reliance on it is not. The ethical problem is less the individual pill than the schedule that makes the pill seem necessary.
Practical considerations for a resident who chooses to use one
Regardless of the ethics, some practical guidance reduces harm:
- Get a prescription. Shift work disorder is an approved indication, and a physician who prescribes for you creates a medical record, checks interactions, and keeps you within the law.
- Dose early in the shift. Modafinil’s half-life of 12 to 15 hours means a dose at midnight will still be active when you try to sleep post-call at noon. A dose at the start of an evening shift is more sensible.
- Never take it for the first time on call. Headache, nausea, and anxiety are common early side effects, and you do not want to discover them while managing a code.
- Do not stack it on high-dose caffeine. The combination raises heart rate and anxiety without adding much attention.
- Remember the interactions. Modafinil induces CYP3A4 and reduces the effectiveness of hormonal contraception, which is relevant to a large share of residents.
- Protect post-call sleep. The recovery sleep is when the debt is actually repaid. Do whatever it takes to get it.
- Notice the pattern. If you find yourself using it on non-call days to compensate for the sleep it cost you, the loop is running and you need to stop.
Prescription rules for these drugs vary between countries, a physician should be involved, and none of this replaces adequate sleep between shifts.
What programs and institutions could do
The residency system has options that do not involve pharmacology:
| Intervention | Evidence for reducing errors | Adoption |
| Duty-hour limits with enforcement | Moderate, reduces serious errors on extended shifts | Widespread but uneven |
| Protected nap periods during call | Good, brief naps reduce lapses | Rare in practice |
| Strategic caffeine guidance | Modest | Informal |
| Night-float systems | Mixed, reduces continuous hours but increases handoffs | Common |
| Screening for sleep disorders in residents | Good, untreated apnea or narcolepsy is a hidden factor | Very rare |
| Open policy on eugeroic use | Unknown, untested | Essentially none |
A program that provided protected nap time, taught residents about circadian timing, screened for sleep disorders, and had an honest conversation about pharmacological countermeasures would be doing far more for patient safety than one that simply looked the other way while some residents obtained a cognitive enhancer on their own.
FAQ
Is it legal for a resident to take modafinil on call? With a valid prescription, yes, in most countries. Without one, it is possession of a controlled substance, with the professional consequences that implies.
Does it improve surgical performance? Simulator studies suggest it improves planning and attention after sleep deprivation but not manual dexterity. It does not make anyone a better surgeon; it reduces the decline sleep loss causes in some cognitive domains.
Will my program find out? It is not detected on standard employment drug screens, which look for amphetamines and other Schedule II drugs. That said, honesty with a prescribing physician is the safer path.
Is it better than coffee for a 24-hour shift? It lasts longer and produces less jitteriness and no crash, but it interferes with post-call sleep if dosed late. Caffeine remains useful for short boosts.
Should hospitals provide it? Most ethicists argue no, because institutional provision normalizes unsafe schedules and creates pressure on residents who do not want to use it.
Final Thoughts
The evidence shows that eugeroics do what residents hope: they sustain attention and executive function through the hours when sleep loss would otherwise erode them, with fewer side effects than the alternatives. The ethics are harder. Occasional, prescribed, well-timed use by an individual resident is defensible and probably safer for patients than the caffeine escalation it replaces. But a training system that leans on a wakefulness-promoting agent to make inhumane schedules survivable has confused a symptom for a solution, and the residents who bear the cost of that confusion deserve a better answer than a pill.
For more topic guides and related resources, visit Modavance.